Knebel et al found that astrocytoma patients (AGII to AGIV/GBM) have increased levels of serum SAA and SAA1 mRNA and protein levels are increased in GBM brain tissue 22. The gene discussed is SAA1; the disease is astrocytoma (excluding glioblastoma).